|
|
|
Insider
Information: |
Worboys Philip D |
Relationship: |
SVP, Research & Transl... |
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
335,062 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$3,209,894 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
335,062 |
|
|
Total
Value |
$3,209,894 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-102.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Theravance Biopharma, Inc. |
TBPH |
SVP, Research & Transl... |
2021-08-20 |
335,062 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
34 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
TBPH |
Theravance Biopharma, Inc... |
SVP, Translational ScienceOffi |
|
2016-03-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
74,943 |
|
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Translational Science |
|
2016-08-20 |
4 |
D |
$27.89 |
$58,681 |
D/D |
(2,104) |
177,436 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Translational Science |
|
2016-11-20 |
4 |
D |
$31.96 |
$67,244 |
D/D |
(2,104) |
175,332 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Translational Science |
|
2016-05-20 |
4 |
D |
$20.55 |
$43,258 |
D/D |
(2,105) |
179,540 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Translational Science |
|
2019-05-20 |
4 |
D |
$19.84 |
$45,076 |
D/D |
(2,272) |
269,399 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Translational Science |
|
2019-08-20 |
4 |
D |
$21.51 |
$48,871 |
D/D |
(2,272) |
267,127 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Research & Transl Science |
|
2019-11-20 |
4 |
D |
$17.60 |
$39,987 |
D/D |
(2,272) |
264,855 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Translational Science |
|
2019-02-20 |
4 |
D |
$27.00 |
$107,622 |
D/D |
(3,986) |
270,644 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Research & Transl Science |
|
2020-12-03 |
4 |
S |
$18.00 |
$76,428 |
D/D |
(4,246) |
319,395 |
0 |
% |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Research & Transl Science |
|
2021-08-20 |
4 |
D |
$14.05 |
$60,513 |
D/D |
(4,307) |
335,062 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Research & Transl Science |
|
2021-05-20 |
4 |
D |
$17.80 |
$76,718 |
D/D |
(4,310) |
339,369 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Translational Science |
|
2018-11-20 |
4 |
D |
$24.79 |
$108,407 |
D/D |
(4,373) |
162,380 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Translational Science |
|
2018-02-20 |
4 |
D |
$29.09 |
$132,825 |
D/D |
(4,566) |
163,563 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Research & Transl Science |
|
2020-08-20 |
4 |
D |
$18.22 |
$87,529 |
D/D |
(4,804) |
328,448 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Research & Transl Science |
|
2020-05-20 |
4 |
D |
$26.67 |
$128,203 |
D/D |
(4,807) |
350,355 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Research & Transl Science |
|
2020-11-20 |
4 |
D |
$17.21 |
$82,728 |
D/D |
(4,807) |
323,641 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Translational Science |
|
2017-08-20 |
4 |
D |
$27.40 |
$150,755 |
D/D |
(5,502) |
164,632 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Translational Science |
|
2017-05-20 |
4 |
D |
$36.83 |
$202,675 |
D/D |
(5,503) |
170,134 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Translational Science |
|
2017-11-20 |
4 |
D |
$28.58 |
$157,276 |
D/D |
(5,503) |
159,129 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Translational Science |
|
2018-08-20 |
4 |
D |
$26.95 |
$148,441 |
D/D |
(5,508) |
173,146 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Translational Science |
|
2018-09-12 |
4 |
S |
$28.50 |
$182,201 |
D/D |
(6,393) |
166,753 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Research & Transl Science |
|
2021-03-09 |
4 |
S |
$20.00 |
$176,580 |
D/D |
(8,829) |
343,679 |
0 |
% |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Translational Science |
|
2017-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
184,332 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Translational Science |
|
2018-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
168,129 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Translational Science |
|
2017-02-20 |
4 |
D |
$33.78 |
$351,211 |
D/D |
(10,397) |
173,935 |
0 |
- |
|
34 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|